Clinical Trials
41 trialsEnzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
M.D. Anderson Cancer Center
LumiNOde
N.N. Petrov National Medical Research Center of Oncology
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65
Cedars-Sinai Medical Center
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
Memorial Sloan Kettering Cancer Center
INFINITE
St. Antonius Hospital
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
M.D. Anderson Cancer Center
RIDES
Clinical Hospital Center Rijeka
Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
University of Miami
IORT-Sein
Institut du Cancer de Montpellier - Val d'Aurelle
To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria
Nova Scotia Health Authority
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Is Breast Massage Necessary to Find Sentinel Lymph Node?
Celal Bayar University
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Alliance for Clinical Trials in Oncology
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer
Fudan University
Ultrasonographic Axillary Localization
Mansoura University
Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
UNICANCER
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
University Hospital Ostrava
Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer
Kahramanmaras Sutcu Imam University
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer
Bulent Ecevit University
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
Washington University School of Medicine
Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy
Washington University School of Medicine
Z0011-China
Shandong Cancer Hospital and Institute
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Jilin University
Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer
University of Miami
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
University of Arkansas
Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy
Cedars-Sinai Medical Center
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
Alliance for Clinical Trials in Oncology
GATA
Institut Cancerologie de l'Ouest
SN-FNAC
Centre hospitalier de l'Université de Montréal (CHUM)
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
University of Southern California
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
National Cancer Institute (NCI)
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes
Washington University School of Medicine
Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer
National Cancer Institute (NCI)
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Barbara Ann Karmanos Cancer Institute
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
National Institutes of Health Clinical Center (CC)
Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast Carcinoma
European Institute of Oncology
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Virginia Commonwealth University